Clinical Trial Update: Study of YK012 in B-cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for YK012 in B-cell acute lymphoblastic leukemia (Phase 1/Phase 2) by Excyte Biopharma Ltd; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• YK012

Snippet

Sponsor: Excyte Biopharma Ltd | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING